Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alpha-(2,4-dichlorophenyl)-4-(1,1,3,3-tetramethylbutyl)-o-cresol
2. Octofene
3. Phenol, 2-((2,4-dichlorophenyl)methyl)-4-(1,1,3,3-tetramethylbutyl)-
1. 37693-01-9
2. Octofene
3. Clofoctol [inn]
4. Alpha-(2,4-dichlorophenyl)-4-(1,1,3,3-tetramethylbutyl)-o-cresol
5. 2-[(2,4-dichlorophenyl)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol
6. Nsc-758389
7. 2-((2,4-dichlorophenyl)methyl)-4-(1,1,3,3-tetramethylbutyl)phenol
8. Clofoctol (inn)
9. Phenol, 2-((2,4-dichlorophenyl)methyl)-4-(1,1,3,3-tetramethylbutyl)-
10. 704083ni0r
11. Ncgc00095016-01
12. Clofoctolum
13. 2-(2,4-dichlorobenzyl)-4-(1,1,3,3-tetramethylbutyl)phenol
14. Dsstox_cid_25889
15. Dsstox_rid_81203
16. Dsstox_gsid_45889
17. 2-[2,4-dichlorobenzyl]-4-[1,1,3,3-tetramethylbutyl]phenol
18. .alpha.-(2,4-dichlorophenyl)-4-(1,1,3,3-tetramethylbutyl)-o-cresol
19. Clofoctolum [inn-latin]
20. Einecs 253-632-6
21. Cas-37693-01-9
22. Brn 2478182
23. Gramplus
24. Phenol, 2-[(2,4-dichlorophenyl)methyl]-4-(1,1,3,3-tetramethylbutyl)-
25. Unii-704083ni0r
26. Octofene (tn)
27. Spectrum_001533
28. Clofoctol [mi]
29. Spectrum2_001533
30. Spectrum3_001565
31. Spectrum4_000161
32. Spectrum5_001082
33. Clofoctol [mart.]
34. Clofoctol [who-dd]
35. Bspbio_003070
36. Kbiogr_000641
37. Kbioss_002013
38. Mls002207309
39. Clofoctol, Analytical Standard
40. Divk1c_000426
41. Schembl147809
42. Spectrum1503206
43. Spbio_001346
44. Chembl1476605
45. Dtxsid5045889
46. Hms501f08
47. Kbio1_000426
48. Kbio2_002013
49. Kbio2_004581
50. Kbio2_007149
51. Kbio3_002570
52. Chebi:108581
53. Ninds_000426
54. Glxc-25630
55. Hms1922i09
56. Pharmakon1600-01503206
57. 2-(2,4-dichlorobenzyl)-4-(2,4,4-trimethylpentan-2-yl)phenol
58. Hy-b1150
59. Zinc2149829
60. Tox21_111389
61. Ccg-39311
62. Nsc758389
63. Akos024374914
64. Tox21_111389_1
65. Cs-4755
66. Db13237
67. Nsc 758389
68. Idi1_000426
69. Ncgc00095016-02
70. Ncgc00095016-03
71. Ncgc00095016-05
72. Smr001306814
73. Sbi-0051786.p002
74. Ft-0704662
75. Sw220062-1
76. D07244
77. Ab00052326_04
78. Ab00052326_05
79. Sr-01000872766
80. Q3680895
81. Sr-01000872766-1
82. Brd-k02900412-001-04-8
83. Brd-k02900412-001-05-5
84. Brd-k02900412-001-07-1
85. 2-(2,4-dichlorobenzyl)-4-(1,1,3,3-tetramethylbutyl)phenol #
| Molecular Weight | 365.3 g/mol |
|---|---|
| Molecular Formula | C21H26Cl2O |
| XLogP3 | 8.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 5 |
| Exact Mass | 364.1360708 g/mol |
| Monoisotopic Mass | 364.1360708 g/mol |
| Topological Polar Surface Area | 20.2 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 401 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01X - Other antibacterials
J01XX - Other antibacterials
J01XX03 - Clofoctol
Global Sales Information
ABOUT THIS PAGE
A Clofoctol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clofoctol, including repackagers and relabelers. The FDA regulates Clofoctol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clofoctol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Clofoctol supplier is an individual or a company that provides Clofoctol active pharmaceutical ingredient (API) or Clofoctol finished formulations upon request. The Clofoctol suppliers may include Clofoctol API manufacturers, exporters, distributors and traders.
Clofoctol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clofoctol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clofoctol GMP manufacturer or Clofoctol GMP API supplier for your needs.
A Clofoctol CoA (Certificate of Analysis) is a formal document that attests to Clofoctol's compliance with Clofoctol specifications and serves as a tool for batch-level quality control.
Clofoctol CoA mostly includes findings from lab analyses of a specific batch. For each Clofoctol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clofoctol may be tested according to a variety of international standards, such as European Pharmacopoeia (Clofoctol EP), Clofoctol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clofoctol USP).
LOOKING FOR A SUPPLIER?
